EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

Brussels, 5 July 2021 From micro-organism production of the world’s vitamin B2, a revolution in cancer therapy using our own immune systems, and the first Covid mRNA vaccine approved – these are just a few examples of the selected landmarks in biotechnology that were officially announced today as the start of EuropaBio’s 25th Anniversary programme.… Continue reading EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

Novartis is proud to support the EuropaBio 25th Anniversary

Brussels, Belgium – 14 June 2021 – EuropaBio today announced that Novartis, the Swiss pharma company, has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor. Novartis, which itself celebrates 25 years since its creation through the merger of Ciba-Geigy and Sandoz in 1996, has the purpose of remaining medicine to improve and extend people’s… Continue reading Novartis is proud to support the EuropaBio 25th Anniversary

Interview with… Cyrille Pauthenier, CEO of Abolis

EuropaBio sat down with new member (and Anniversary sponsor) Abolis, to find out about their journey from creation in 2014. 1) What inspired the foundation of Abolis? Abolis Biotechnologies is inspired by a strong conviction.I was an enthusiast student in chemistry when I first came to the lab and made an organic chemistry synthesis with… Continue reading Interview with… Cyrille Pauthenier, CEO of Abolis